The Ubiquitin-Proteasome System (UPS) and the Mechanism of Action of Bortezomib

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|15|1483-1499

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.15, 2011-05, pp. : 1483-1499

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Overview of Proteasome Inhibitor-Based Anti-cancer Therapies: Perspective on Bortezomib and Second Generation Proteasome Inhibitors versus Future Generation Inhibitors of Ubiquitin-Proteasome System

By  

Current Cancer Drug Targets, Vol. 14, Iss. 6, 2014-07 ,pp. : 517-536

Bentham Science Publishers

Access to resources Recommend Favorite

The ubiquitin–proteasome system and assays to determine responses to inhibitors

By Tsvetkov Lyuben   Nanjundan Meera   Domino Maria   Daniel Kenyon G  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 12, 2010-12 ,pp. : 1221-1236

Informa Healthcare

Access to resources Recommend Favorite

Targeting the ubiquitin-proteasome system for cancer therapy

By Shen Min  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 9, 2013-09 ,pp. : 1091-1108

Informa Healthcare

Access to resources Recommend Favorite

Emerging Role of the Ubiquitin-proteasome System as Drug Targets

By  

Current Pharmaceutical Design, Vol. 19, Iss. 18, 2013-06 ,pp. : 3175-3189

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Plasmodium Ubiquitin/Proteasome System with Anti- Malarial Compounds: Promises for the Future

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 10, Iss. 3, 2010-06 ,pp. : 158-164

Bentham Science Publishers

Access to resources Recommend Favorite